Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antiviral Drugs Market
Antiviral Drugs Market Share
- Report ID: GMI4968
- Published Date: Mar 2022
- Report Format: PDF
Antiviral Drugs Market Share
Some of the notable key market players operating in the antiviral drug industry include :
- Gilead Sciences
- AbbVie, Inc.
- Merck & Co.
- GlaxoSmithKline plc
- Aurobindo Pharma Limited.
- ohnson & Johnson
- Sun Pharmaceutical Industries Ltd.
- Cipla, Inc.
- Mylan N V
- Bristol-Myers Squibb
These industry players are adopting several growth strategies to strengthen product offerings and attain sustainable competitive advantage.
Frequently Asked Questions (FAQ) :
Global market size for antiviral drugs exceeded USD 48 billion in 2021 and is anticipated to grow at a CAGR of 3.4% between 2022 and 2028 considering the higher incidence rate of infectious diseases.
Branded antiviral drugs industry value is expected to grow at a CAGR of 2.9% through 2028 driven by the rising product adoption and availability in developed markets.
North American market for antiviral drugs accounted for more than 56% of the total industry value in 2021 and will record substantial growth over 2022-2028 owing to the escalating number of product approvals.
Key participants in the antiviral drugs industry comprise Aurobindo Pharma Limited, Gilead Sciences, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Cipla, Inc., Johnson & Johnson, and others.
Antiviral Drugs Market Scope
×
Get a free sample of
Antiviral Drugs Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below